ECTRIMS 2018: The Gut Microbiome in MS

“It is intriguing…can you modulate the gut microbiome to improve outcomes in MS, such as reducing relapse rates? That would be a fabulous end goal!” – Prof Helen Tremlett.

The potential role of the gut microbiome in multiple sclerosis (MS) is an exciting new avenue of research. At ECTRIMS 2018, MStranslate co-founder and chief science communicator, Brett Drummond, chatted to one of the world leaders in this area, Professor Helen Tremlett from the University of British Columbia.

In this interview, Professor Tremlett discusses her research sequencing the microbiome from children with paediatric MS and what outcomes might be possible from this work.

If you have any questions regarding this work, please don’t hesitate to ask them below or, alternatively, you can visit any of our social media platforms ask them there.  As always, we would love to hear your own thoughts and opinions on this topic.